159 related articles for article (PubMed ID: 36781796)
21. Advances in high-resolution quantitative proteomics: implications for clinical applications.
Gallien S; Domon B
Expert Rev Proteomics; 2015; 12(5):489-98. PubMed ID: 26189960
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of Multiple Reaction Monitoring (MRM) Assays for Clinical Applications.
Kontostathi G; Makridakis M; Bitsika V; Tsolakos N; Vlahou A; Zoidakis J
Methods Mol Biol; 2019; 1959():205-223. PubMed ID: 30852825
[TBL] [Abstract][Full Text] [Related]
23. Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM).
Gallien S; Kim SY; Domon B
Mol Cell Proteomics; 2015 Jun; 14(6):1630-44. PubMed ID: 25755295
[TBL] [Abstract][Full Text] [Related]
24. Clinical applications of quantitative proteomics using targeted and untargeted data-independent acquisition techniques.
Meyer JG; Schilling B
Expert Rev Proteomics; 2017 May; 14(5):419-429. PubMed ID: 28436239
[TBL] [Abstract][Full Text] [Related]
25. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
[TBL] [Abstract][Full Text] [Related]
26. Targeted
Cho BG; Gutierrez Reyes CD; Goli M; Gautam S; Banazadeh A; Mechref Y
Anal Chem; 2022 Nov; 94(44):15215-15222. PubMed ID: 36301778
[TBL] [Abstract][Full Text] [Related]
27. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics.
Peterson AC; Russell JD; Bailey DJ; Westphall MS; Coon JJ
Mol Cell Proteomics; 2012 Nov; 11(11):1475-88. PubMed ID: 22865924
[TBL] [Abstract][Full Text] [Related]
28. Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.
Shi T; Su D; Liu T; Tang K; Camp DG; Qian WJ; Smith RD
Proteomics; 2012 Apr; 12(8):1074-92. PubMed ID: 22577010
[TBL] [Abstract][Full Text] [Related]
29. From shotgun to targeted proteomics: rapid Scout-MRM assay development for monitoring potential immunomarkers in Dreissena polymorpha.
Leprêtre M; Palos-Ladeiro M; Faugere J; Almunia C; Lemoine J; Armengaud J; Geffard A; Salvador A
Anal Bioanal Chem; 2020 Oct; 412(26):7333-7347. PubMed ID: 32808052
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptidomics: Comparison of parallel reaction monitoring and data-independent acquisition for the analysis of neuropeptides using high-resolution mass spectrometry.
Saidi M; Kamali S; Beaudry F
Biomed Chromatogr; 2019 Jul; 33(7):e4523. PubMed ID: 30821847
[TBL] [Abstract][Full Text] [Related]
31. Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.
Parker CE; Borchers CH
Mol Oncol; 2014 Jun; 8(4):840-58. PubMed ID: 24713096
[TBL] [Abstract][Full Text] [Related]
32. Targeted liquid chromatography-tandem mass spectrometry analysis of proteins: Basic principles, applications, and perspectives.
Kulyyassov A; Fresnais M; Longuespée R
Proteomics; 2021 Dec; 21(23-24):e2100153. PubMed ID: 34591362
[TBL] [Abstract][Full Text] [Related]
33. Establishing a reliable multiple reaction monitoring-based method for the quantification of obesity-associated comorbidities in serum and adipose tissue requires intensive clinical validation.
Oberbach A; Schlichting N; Neuhaus J; Kullnick Y; Lehmann S; Heinrich M; Dietrich A; Mohr FW; von Bergen M; Baumann S
J Proteome Res; 2014 Dec; 13(12):5784-800. PubMed ID: 25318410
[TBL] [Abstract][Full Text] [Related]
34. Qualification and Verification of Protein Biomarker Candidates.
Zhao Y; Brasier AR
Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
[TBL] [Abstract][Full Text] [Related]
35. Four-dimensional proteomics analysis of human cerebrospinal fluid with trapped ion mobility spectrometry using PASEF.
Mun DG; Budhraja R; Bhat FA; Zenka RM; Johnson KL; Moghekar A; Pandey A
Proteomics; 2023 May; 23(10):e2200507. PubMed ID: 36752121
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer.
Hoffman MA; Fang B; Haura EB; Rix U; Koomen JM
J Proteome Res; 2018 Jan; 17(1):63-75. PubMed ID: 29164889
[TBL] [Abstract][Full Text] [Related]
37. Targeted proteomics strategy applied to biomarker evaluation.
Kim YJ; Gallien S; van Oostrum J; Domon B
Proteomics Clin Appl; 2013 Dec; 7(11-12):739-47. PubMed ID: 24123942
[TBL] [Abstract][Full Text] [Related]
38. MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum.
Chambers AG; Percy AJ; Simon R; Borchers CH
Expert Rev Proteomics; 2014 Apr; 11(2):137-48. PubMed ID: 24476379
[TBL] [Abstract][Full Text] [Related]
39. Multiplex targeted mass spectrometry assay for one-shot flavivirus diagnosis.
Wee S; Alli-Shaik A; Kek R; Swa HLF; Tien WP; Lim VW; Leo YS; Ng LC; Hapuarachchi HC; Gunaratne J
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6754-6759. PubMed ID: 30886083
[TBL] [Abstract][Full Text] [Related]
40. Is nontargeted data acquisition for target analysis (nDATA) in mass spectrometry a forward-thinking analytical approach?
Abdollahi M; Segura PA; Beaudry F
Biomed Chromatogr; 2023 Jul; 37(7):e5531. PubMed ID: 36269018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
